1-6 of 379 Activities
In this CME Outfitters live Q&A, expert faculty will answer questions about the multifaceted impact of GLP-1 RA therapies on glycemic control, CV health, weight management, renal health, liver health, and overall T2D complication risk.
In this CME Outfitters livestream symposium, expert faculty will guide learners on the implementation of routine HIV testing and on adopting a status-neutral approach to effectively promote prevention strategies and PrEP initiation. Faculty will evaluate current and emerging PrEP options, introduce emerging LAI PrEP options, and discuss optimal patient selection criteria, transitioning strategies, and monitoring considerations. Faculty will model integration of effective patient engagement strategies to collaboratively initiate PrEP treatment and support adherence.
In this CME Outfitters live webcast, an expert health care professional and an experienced LGS caregiver will discuss the intricacies of adult care for LGS, including the key differences between pediatric and adult care in LGS as well as best practices for collaboration with the adult care team in the management of LGS.
In this CME Outfitters live webcast, expert faculty will discuss strategies to care for patients with LGS as they reach adulthood, including how to manage and prevent behavioral issues in adult patients with LGS, the development of in-depth seizure action plans, improving communication with group homes and long-term care centers, and strategies for effective collaboration with patients, caregivers, and the interdisciplinary care team for LGS.
In this CME Outfitters live webcast, expert faculty will discuss strategies to better assess the impact of diagnostic delays in IH and narcolepsy, differentiate the effects of treatment selections, with an emphasis on CV risk and patient-specific considerations, and evaluate the sleep/wake cycle and its relationship to narcolepsy and IH to optimize its evaluation and management.
In this CME Outfitters recorded webcast, expert faculty will discuss the role of FcRn in the pathogenesis of gMG, evaluate the safety and efficacy of FcRn antagonists for the treatment of gMG, and provide expert guidance on how to identify patients with gMG who may be appropriate candidates for treatment with FcRn antagonists. Finally, they will model development of optimized and individualized treatment plans for patients with gMG receiving FcRn antagonists, providing learners with key skills to bring back to clinical practice.
